The production of basic pharmaceutical products and pharmaceutical preparations in Germany has shown fluctuating trends from 2013 through 2023. After a significant dip in 2017, the industry rebounded with notable increases in 2018 and 2021. The production value in 2023 stood at 58.54 billion euros, marking a modest 2.04% year-on-year increase from 2022 and continuing an average annual growth rate (CAGR) of 0.57% over the last five years.
Looking forward, the forecasted data from 2024 to 2028 suggest a steady upward trend, with the production value expected to reach 64.97 billion euros by 2028. The average annual growth rate over the next five years is projected to be 1.53%, indicating a relatively stable growth trajectory.
Future trends to watch for:
- Increasing R&D investments and advancements in biotechnology could boost production efficiency and output.
- Regulatory changes and healthcare policies within the EU could impact production dynamics significantly.
- Innovation in drug delivery systems and personalized medicine are likely to drive growth in the coming years.
- Global health crises or pandemics could lead to sudden surges in demand, influencing production scales and strategies.
